Female Reproductive System Disease disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: FML039 MIFTS: 36	Female Reproductive System Disease Categories: Reproductive diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs Expand all tables

Sources

Aliases & Classifications for Female Reproductive System Disease

MalaCards integrated aliases for Female Reproductive System Disease:

Name: Female Reproductive System Disease ¹² ¹⁵ ¹⁷

Female Reproductive System Disorder ⁷⁰

Genital Diseases, Female ⁴⁴

Classifications:

MalaCards categories:
Anatomical: Reproductive diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:229

ICD9CM ³⁴ 629.9

MeSH ⁴⁴ D005831

SNOMED-CT ⁶⁷ 38233001

EFO ¹⁷ EFO_0009549

UMLS ⁷⁰ C0017411 C0236100

Sources

Summaries for Female Reproductive System Disease

Disease Ontology : ¹² A reproductive system disease that impairs the ability to reproduce and is located in the uterus, vagina, cervix, ovaries or fallopian tubes.

MalaCards based summary : Female Reproductive System Disease, also known as female reproductive system disorder, is related to uterine anomalies and endometriosis, and has symptoms including menometrorrhagia, mastodynia and breast engorgement. An important gene associated with Female Reproductive System Disease is MIR199A1 (MicroRNA 199a-1), and among its related pathways/superpathways are MicroRNAs in cancer and miRNA targets in ECM and membrane receptors. The drugs Paclitaxel and Bevacizumab have been mentioned in the context of this disorder. Affiliated tissues include uterus, cervix and breast.

Wikipedia : ⁷³ The female reproductive system is made up of the internal and external sex organs that function in... more...

Sources

Related Diseases for Female Reproductive System Disease

Diseases related to Female Reproductive System Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 221)

#	Related Disease	Score	Top Affiliating Genes
1	uterine anomalies	32.7	MIR9-1 MIR518D MIR34A MIR30A MIR27A MIR214
2	endometriosis	32.7	MIR200B MIR200A MIR199A1 MIR145 MIR143 MIR141
3	endometriosis of ovary	32.7	MIR9-1 MIR145 MIR141
4	preterm premature rupture of the membranes	11.2
5	ectopic pregnancy	11.2
6	pelvic inflammatory disease	11.2
7	fallopian tube endometriosis	11.2
8	endosalpingiosis	11.2
9	endometriosis of intestine	11.2
10	endometriosis of pelvic peritoneum	11.2
11	endometriosis in scar of skin	11.2
12	endometriosis of rectovaginal septum and vagina	11.2
13	vaginal disease	11.2
14	hernia of ovary and fallopian tube	11.2
15	prolapse of female genital organ	11.2
16	amenorrhea	11.2
17	masters-allen syndrome	11.2
18	fallopian tube disease	11.2
19	vulvar disease	11.2
20	vulvovaginitis	11.2
21	gynatresia	11.2
22	parovarian cyst	11.2
23	bartholin's gland disease	11.2
24	bartholin's duct cyst	11.2
25	bile duct adenocarcinoma	10.7	MIR9-1 MIR30A MIR21 MIR199A1 MIR196A1 MIR17
26	glucose metabolism disease	10.7	MIR9-1 MIR30A MIR27A MIR21 MIR199A1 MIR196A1
27	ovary epithelial cancer	10.7	MIR9-1 MIR30A MIR21 MIR200A MIR199A1 MIR196A1
28	malignant ovarian surface epithelial-stromal neoplasm	10.7	MIR9-1 MIR30A MIR21 MIR200A MIR199A1 MIR196A1
29	central nervous system cancer	10.7	MIR9-1 MIR34A MIR30A MIR21 MIR199A1 MIR196A1
30	ovarian serous carcinoma	10.7	MIR27A MIR214 MIR21 MIR200B MIR200A MIR199A1
31	cell type benign neoplasm	10.7	MIR30A MIR21 MIR200A MIR199A1 MIR196A1 MIR193A
32	autoimmune disease of musculoskeletal system	10.7	MIR34A MIR30A MIR27A MIR21 MIR199A1 MIR196A1
33	leukocyte disease	10.7	MIR30A MIR27A MIR21 MIR200B MIR199A1 MIR196A1
34	squamous cell carcinoma, head and neck	10.7	MIR9-1 MIR214 MIR21 MIR205 MIR200A MIR199A1
35	bone marrow cancer	10.7	MIR9-1 MIR34A MIR30A MIR27A MIR21 MIR199A1
36	ovarian disease	10.7	MIR9-1 MIR30A MIR27A MIR21 MIR200B MIR200A
37	disease by infectious agent	10.7	MIR9-1 MIR34A MIR30A MIR27A MIR214 MIR21
38	intestinal benign neoplasm	10.7	MIR21 MIR199A1 MIR196A1 MIR17 MIR145 MIR143
39	sensory system disease	10.7	MIR9-1 MIR30A MIR27A MIR214 MIR21 MIR199A1
40	central nervous system disease	10.7	MIR9-1 MIR34A MIR30A MIR27A MIR21 MIR199A1
41	nervous system cancer	10.7	MIR9-1 MIR34A MIR30A MIR27A MIR214 MIR21
42	upper respiratory tract disease	10.7	MIR9-1 MIR30A MIR27A MIR21 MIR199A1 MIR196A1
43	acquired metabolic disease	10.7	MIR9-1 MIR34A MIR30A MIR27A MIR21 MIR200A
44	nasopharyngeal disease	10.7	MIR9-1 MIR30A MIR27A MIR21 MIR199A1 MIR196A1
45	arteries, anomalies of	10.7	MIR9-1 MIR34A MIR30A MIR27A MIR214 MIR21
46	autonomic nervous system neoplasm	10.7	MIR9-1 MIR34A MIR30A MIR27A MIR21 MIR199A1
47	pharynx cancer	10.7	MIR9-1 MIR30A MIR27A MIR21 MIR199A1 MIR196A1
48	oral cavity cancer	10.7	MIR9-1 MIR30A MIR21 MIR205 MIR199A1 MIR196A1
49	peripheral nervous system neoplasm	10.7	MIR9-1 MIR34A MIR30A MIR27A MIR21 MIR199A1
50	esophageal disease	10.7	MIR34A MIR30A MIR21 MIR200B MIR200A MIR199A1

Graphical network of the top 20 diseases related to Female Reproductive System Disease:

Sources

Symptoms & Phenotypes for Female Reproductive System Disease

UMLS symptoms related to Female Reproductive System Disease:

menometrorrhagia; mastodynia; breast engorgement; nipple discharge; leukorrhea; vaginal pruritus; vaginal odor; vaginal discomfort; pruritus vulvae; genital itching; perineal pain female; genitalia external painful; menopausal symptoms; vaginal pain; burning feeling vagina; mastoscirrhus; discomfort of vulva

Sources

Drugs & Therapeutics for Female Reproductive System Disease

Drugs for Female Reproductive System Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Paclitaxel

Approved, Vet_approved

Phase 3

33069-62-4

36314

Synonyms:

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

157069-30-2

33069-62-4

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

7 Epi taxol

7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.

7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.

7-epi-Paclitaxel

7-Epipaclitaxel

7-Epi-paclitaxel

7-epi-Taxol

7-Epitaxol

7-Epi-taxol

AB00513812

ABI 007

abi-007

ABI007

ABI-007

Abraxane

Abraxane (TN)

Abraxane I.V. Suspension

Abraxis BioScience brand of albumin-bound paclitaxel

AC1L1IOG

AC1L1VJI

AC1L9AVF

AC-675

ACon1_002231

albumin-bound paclitaxel

Ambotz33069-62-4

ANX-513

Anzatax

Asotax

BIDD:PXR0046

Bio-0076

Bio1_000362

Bio1_000851

Bio1_001340

Bio2_000416

Bio2_000896

BMS 181339-01

BMS-181339

BMS-181339-01

BPBio1_000320

BRD-A23723433-001-01-2

BRD-A28746609-001-04-0

BRD-K62008436-001-03-1

Bris taxol

Bristaxol

BSPBio_000290

BSPBio_001152

BSPBio_002614

C07394

C466458

C47H51NO14

Capxol

CCRIS 8143

CHEBI:103439

CHEBI:45863

CHEMBL100910

CHEMBL418410

CHEMBL48

CID36314

CID441276

CID4666

CID6713921

CID6915727

cMAP_000068

CPD-8718

D00491

DB01229

DHP-107

DHP-208

DivK1c_000441

DRG-0190

DTS-301

Ebetaxel

EmPAC

Epitaxol

EU-0101201

Genaxol

Genetaxyl

Genexol

Genexol-PM

HMS1362J13

HMS1568O12

HMS1792J13

HMS1922K08

HMS1990J13

HMS2090D07

HMS2093K15

HMS501G03

HSDB 6839

I06-0014

IDI1_000441

IDI1_002171

Intaxel

KBio1_000441

KBio2_000492

KBio2_002016

KBio2_002509

KBio2_003060

KBio2_004584

KBio2_005077

KBio2_005628

KBio2_007152

KBio2_007645

KBio3_000903

KBio3_000904

KBio3_001834

KBio3_002987

KBioGR_000492

KBioGR_001893

KBioGR_002509

KBioSS_000492

KBioSS_002016

KBioSS_002517

LipoPac

LMPR0104390001

Lopac0_001201

LS-31070

MBT 0206

MEGxp0_001940

Micellar Paclitaxel

Mitotax

MLS000863266

MLS001077297

MLS002154218

MLS002172439

MLS002695976

MolPort-001-742-627

MolPort-003-665-783

MolPort-003-932-365

MPI-5018

nab-paclitaxel

Nanotaxel

NCGC00024995-02

NCGC00024995-03

NCGC00024995-04

NCGC00024995-05

NCGC00024995-06

NCGC00024995-07

NCGC00164367-01

NCGC00164367-02

NCGC00164367-03

nchembio.188-comp1

nchembio.2007.34-comp9

nchembio.215-comp9

nchembio853-comp6

NCI60_000601

Neuro_000060

NINDS_000441

NK 105

Nova-12005

NP-010981

NSC 125973

NSC125973

NSC-125973

NSC358882

OAS-PAC-100

OncoGel

Onxal

Onxol

Onxol, Taxol, Nov-Onxol, Paclitaxel

P1632

Paclical

Pacligel

paclitaxel

Paclitaxel

Paclitaxel (JAN/USP)

Paclitaxel (JAN/USP/INN)

Paclitaxel (Taxol)

Paclitaxel [USAN:INN:BAN]

Paclitaxel, (4 alpha)-isomer

Paxceed

Paxene

Paxoral

Plaxicel

Praxel

Prestwick0_000155

Prestwick1_000155

Prestwick2_000155

Prestwick3_000155

Probes2_000350

QW 8184

S1150_Selleck

S-8184 Paclitaxel Injectable Emulsion

SDCCGMLS-0066823.P001

SDP-013

SMP1_000228

SMR000394086

SMR000857385

SPBio_000943

SPBio_002229

Spectrum_001536

SPECTRUM1503908

Spectrum2_000872

Spectrum3_001057

Spectrum4_001197

Spectrum5_001491

ST50306996

T 7402

T1912_SIGMA

T7191_SIGMA

T7402_SIGMA

TA1

TaxAlbin

Taxol

TAXOL

TAXOL (TN)

Taxol a

Taxol A

Taxol Konzentrat

TAXOL, 10-EPI,

Taxol, bris

Taxol.RTM. (Registered Trademark)

TXL

UNII-P88XT4IS4D

UPCMLD-DP108:001

UPCMLD-DP108:002

Vascular Wrap

weekly paclitaxel

Xorane

Yewtaxan

Bevacizumab

Approved, Investigational

Phase 3

216974-75-3

Synonyms:

216974-75-3

antiVEGF

Anti-VEGF Humanized Monoclonal Antibody

anti-VEGF monoclonal antibody

Anti-VEGF monoclonal antibody

Avastin

Avastin (TN)

bevacizumab

Bevacizumab

Bevacizumab (genetical recombination)

Bevacizumab (genetical recombination) (JAN)

bevacizumab-awwb

D06409

R-435

rhuMAb-VEGF

Carboplatin

Approved

Phase 3

41575-94-4

10339178 498142 38904

Synonyms:

(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum

/h1-3H2,(H,7,8)(H,9,10)

1,1-Cyclobutanedicarboxylate diammine platinum (II)

1,1-Cyclobutanedicarboxylate diammine platinum(II)

2*-1

2*1H2

41575-94-4

70903-55-8

AC-1457

AC1L8I6U

Ambap41575-94-4

azanide

Blastocarb

BSPBio_003145

C 2538

C2043

C2538_SIGMA

C6H10N2O4Pt

Carbopaltin

Carboplat

carboplatin

Carboplatin

Carboplatin (JAN/USP/INN)

Carboplatin (USAN)

Carboplatin [USAN:INN:BAN:JAN]

Carboplatine

Carboplatine [French]

Carboplatino

Carboplatino [Spanish]

Carboplatinum

Carboplatinum [Latin]

Carbosin

Carbotec

Cbdca

CBDCA

CCRIS 3404

CHEBI:31355

CHEMBL1351

CHEMBL288376

CID10339178

CID2567

CID38904

CID426756

CID498142

CID5352133

CID6398587

CID6603770

cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum

cis-(1,1-cyclobutanedicarboxylato)diammineplatinum(II)

cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)

cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)

cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)

cis-Diammine(1,1-cyclobutanedicarboxylato) platinum

cis-diammine(1,1-cyclobutanedicarboxylato)platinum

cis-Diammine(1,1-cyclobutanedicarboxylato)platinum

cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II)

cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)

cis-Diammine(cyclobutanedicarboxylato)platinum II

Cyclobutane-1,1-dicarboxylate

cyclobutane-1,1-dicarboxylic acid

D01363

DB00958

Diammine(1,1-cyclobutanedicarboxylato)platinum (II)

Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum

diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum

Diammine-1,1-cyclobutane dicarboxylate platinum II

DivK1c_000892

EINECS 255-446-0

Ercar

EU-0100230

HMS1921J16

HMS2090M05

HMS2092B22

HMS502M14

HSDB 6957

I14-2390

IDI1_000892

InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6

IUPAC: Azane

JM 8

JM8

JM-8

KBio1_000892

KBio2_002009

KBio2_004577

KBio2_007145

KBio3_002645

KBioGR_000713

KBioSS_002009

Lopac0_000230

Lopac-C-2538

LS-117689

MolPort-003-665-501

MolPort-003-845-609

NCGC00015223-01

NCGC00093695-01

NCGC00094961-01

NCGC00094961-02

NCGC00094961-03

NCGC00162099-01

NCGC00162099-02

NCGC00167800-01

NCGC00178242-01

nchembio.573-comp10

nchembio773-comp2

nchembio873-comp3

Nealorin

Neocarbo

NINDS_000892

NSC 201345

NSC 241240

NSC201345

NSC241240

NSC-241240

Paraplatin

Paraplatin (TN)

Paraplatin, Carboplatin

Paraplatin-AQ

Platinum(+2) Cation

platinum(2+)

Platinum(II), (1, 1-cyclobutanedicar

Platinum, {diammine[1,1-cyclobut

Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)

Ribocarbo

S1215_Selleck

SPBio_000716

Spectrum_001529

SPECTRUM1502106

Spectrum2_000898

Spectrum3_001503

Spectrum4_000337

Spectrum5_001094

UNII-BG3F62OND5

Tubulin Modulators

Phase 3

Angiogenesis Inhibitors

Phase 3

Antineoplastic Agents, Immunological

Phase 3

Antimitotic Agents

Phase 3

Albumin-Bound Paclitaxel

Phase 3

Clotrimazole

Approved, Vet_approved

Phase 2

23593-75-1

2812

Synonyms:

(Chlorotrityl)imidazole

1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole

1-(a-(2-Chlorophenyl)benzhydryl)imidazole

1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole

1-(O-Chloro-a,a-diphenylbenzyl)imidazole

1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole

1-(o-Chlorotrityl)imidazole

1-(O-Chlorotrityl)imidazole

1-(o-Chloro-α,α-diphenylbenzyl)imidazole

1-(O-Chloro-α,α-diphenylbenzyl)imidazole

1-(α-(2-Chlorophenyl)benzhydryl)imidazole

1-(Α-(2-chlorophenyl)benzhydryl)imidazole

117829-71-7

23593-75-1

33894_FLUKA

33894_RIEDEL

3ACDFDF8-38E3-4368-85D0-BDF8AE1E6591

AB00051951

AC1L1EIW

AC-279

B 5097

BAY 5097

Bay b 5097

BAY b 5097

Bay b 9057

BAY b5097

BAY-5097

Bay-B 5097

BAYb 5097

Bayer brand 1 OF clotrimazole

Bayer Brand 1 of Clotrimazole

Bayer brand 2 OF clotrimazole

Bayer Brand 2 of Clotrimazole

BIDD:GT0450

BIDD:PXR0036

Bio-0442

BPBio1_000126

BRN 0622318

BSPBio_000114

BSPBio_002057

C 6019

C06922

C22H17ClN2

C6019_SIGMA

Canesten

Canesten 1-day cream combi-pak

Canesten 1-Day Cream Combi-Pak

Canesten 1-day therapy

Canesten 1-Day Therapy

Canesten 3-day therapy

Canesten 3-Day Therapy

Canesten 6-day therapy

Canesten 6-Day Therapy

Canesten combi-pak 1-day therapy

Canesten Combi-Pak 1-Day Therapy

Canesten combi-pak 3-day therapy

Canesten Combi-Pak 3-Day Therapy

Canesten cream

Canesten Cream

Canesten solution

Canesten Solution

Canestene

Canestine

Canifug

CAS-23593-75-1

CCRIS 6245

CHEBI:3764

CHEMBL104

Chlotrimazole

CID2812

Cimitidine

Clomatin

Clotrimaderm

Clotrimaderm cream

Clotrimazol

Clotrimazol [INN-Spanish]

clotrimazole

Clotrimazole

Clotrimazole (JP15/USP/INN)

Clotrimazole [USAN:INN:BAN:JAN]

Clotrimazole schering brand

Clotrimazole Schering Brand

Clotrimazolum

Clotrimazolum [INN-Latin]

clotrimeizol

CPD000058306

CPD-8926

Cutistad

D00282

D003022

DB00257

Desamix F

DivK1c_000665

DRG-0072

EINECS 245-764-8

Empecid

Esparol

EU-0100315

FB 5097

FB b 5097

Fem care

Fem Care

FemCare

Gino-Lotremine

Gyne lotrimin

Gyne-lotrimin

Gyne-Lotrimin

Gyne-lotrimin 3

Gyne-Lotrimin 3

Gyne-lotrimin 3 combination pack

Gyne-Lotrimin 3 Combination Pack

Gyne-lotrimin combination pack

Gyne-Lotrimin Combination Pack

Gyne-lotrimin3

Gyne-lotrimin3 combination pack

Gynix

HMS1568F16

HMS1920O21

HMS2051E11

HMS2091G10

HMS502B07

HSDB 3266

I01-3474

IDI1_000665

Kanesten

KBio1_000665

KBio2_001823

KBio2_004391

KBio2_006959

KBio3_001277

KBioGR_000850

KBioSS_001823

Klotrimazole

Lopac0_000315

Lopac-C-6019

Lotrimax

Lotrimin

Lotrimin (TN)

Lotrimin af

Lotrimin Af

Lotrimin af cream

Lotrimin AF Cream

Lotrimin af jock-itch cream

Lotrimin AF Jock-Itch Cream

Lotrimin af lotion

Lotrimin AF Lotion

Lotrimin af solution

Lotrimin AF Solution

Lotrimin cream

Lotrimin Cream

Lotrimin lotion

Lotrimin Lotion

Lotrimin solution

Lotrimin Solution

Lotrisone

LS-78271

MLS000028502

MLS000758243

MLS001423972

MolPort-002-557-756

mono-Baycuten

Monobaycuten

Mono-baycuten

Mycelax

Mycelex

Mycelex (TN)

Mycelex 7

Mycelex cream

Mycelex Cream

Mycelex g

Mycelex G

Mycelex otc

Mycelex OTC

Mycelex solution

Mycelex Solution

Mycelex troches

Mycelex Troches

Mycelex twin pack

Mycelex Twin Pack

Mycelex: mycosporinrimazole

Mycelex: MycosporinRimazole

Mycelex-7

Mycelex-7 combination pack

Mycelex-7 Combination Pack

Mycelex-g

Mycelex-G

Myclo cream

Myclo Cream

Myclo solution

Myclo Solution

Myclo spray solution

Myclo Spray Solution

Myclo-gyne

Myclo-Gyne

Mycofug

Mycosporin

Mykosporin

Nalbix

NCGC00015251-01

NCGC00015251-02

NCGC00015251-03

NCGC00015251-09

NCGC00093761-01

NCGC00093761-02

NCGC00093761-03

NCGC00093761-04

NCGC00093761-05

NCGC00093761-06

nchembio.65-comp9

nchembio790-comp30

NCIMech_000609

Neo-zol cream

Neo-Zol Cream

NINDS_000665

NSC 257473

NSC257473

Otomax

Pan-Fungex

Pedisafe

Prestwick_120

Prestwick0_000267

Prestwick1_000267

Prestwick2_000267

Prestwick3_000267

QTL1_000024

Rimazole

S1606_Selleck

SAM001247056

Schering brand OF clotrimazole

Schering Brand of Clotrimazole

SMR000058306

SPBio_000176

SPBio_002333

Spectrum_001343

SPECTRUM1500200

Spectrum2_000128

Spectrum3_000359

Spectrum4_000295

Spectrum5_000781

Stiemazol

STK700023

Tibatin

Trimysten

Trivagizole 3

UNII-G07GZ97H65

Veltrim

ZINC03807804

Miconazole

Approved, Investigational, Vet_approved

Phase 2

22916-47-8

4189

Synonyms:

(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole

1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole

1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole

1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole

1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole

1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole

1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole

1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole

22832-87-7 (NITRATE)

22916-47-8

75319-47-0

AB00053500

AC1L1HM1

Aflorix(nitrate)

AKOS001574474

Albistat(nitrate)

Andergin(nitrate)

BPBio1_000279

BRD-A82396632-001-03-0

BRD-A82396632-008-02-7

Brentan

BRN 0965511

BSPBio_000253

BSPBio_002033

CCRIS 7924

CHEBI:6923

CHEMBL91

CID4189

Conofite(nitrate)

CPD-4501

D00416

Dactarin

Daktarin IV

DB01110

DivK1c_000156

EINECS 245-324-5

Epi-Monistat(nitrate)

Esteve brand OF miconazole

Femizol-M

Florid(nitrate)

Gyno-Daktar(nitrate)

HMS1568M15

HMS2090B21

I14-14342

IDI1_000156

imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)

Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)

Janssen cilag brand OF miconazole

Janssen-cilag brand OF miconazole

Johnston and johnston brand OF miconazole nitrate

KBio1_000156

KBio2_001445

KBio2_004013

KBio2_006581

KBio3_001533

KBioGR_000581

KBioSS_001445

Lotrimin AF(nitrate)

LS-78378

MCZ

Micantin (nitrate)

Miconasil nitrate

Miconasil Nitrate

Miconazol

Miconazol [INN-Spanish]

miconazole

Miconazole

Miconazole (JP15/USP/INN)

Miconazole [USAN:BAN:INN:JAN]

Miconazole 3

Miconazole 3 Combination Pack

Miconazole 7 Combination Pack

Miconazole esteve brand

Miconazole janssen-cilag brand

Miconazole nitrate

Miconazole nitrate salt

Miconazole-7

Miconazolo

Miconazolo [DCIT]

Miconazolum

Miconazolum [INN-Latin]

Micozole

Minostate

MJR 1762

MLS002222203

MolPort-002-557-553

Monazole 7

Monista (nitrate)

Monistat

Monistat (TN)

Monistat 1 Combination Pack

Monistat 3 Dual-Pak

Monistat 3 Vaginal Ovules

Monistat 5 Tampon

Monistat 7 Dual-Pak

Monistat 7 Vaginal Suppositories

Monistat Dual- PAK

Monistat IV

Monistat iv (TN)

Monistat-Derm

NCI60_001353

NCI60_001380

NINDS_000156

Nitrate, miconasil

Nitrate, miconazole

Novo-Miconazole Vaginal Ovules

NSC 170986

NSC169434

NSC170986

Oprea1_091955

Prestwick_335

Prestwick0_000067

Prestwick1_000067

Prestwick2_000067

Prestwick3_000067

R 18134

R-14,889

SMR001307249

SPBio_000976

SPBio_002174

Spectrum_000965

Spectrum2_001048

Spectrum3_000507

Spectrum4_000061

Spectrum5_001297

STK834405

STOCK1S-93556

UNII-7NNO0D7S5M

Vusion

Zimycan

Sirolimus

Approved, Investigational

Phase 2

53123-88-9

6436030 5284616

Synonyms:

(-)-rapamycin

(-)-Rapamycin

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

1fkb

1pbk

23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine

23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine

23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29

3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

53123-88-9

A422989, NSC226080

AC1L1JH9

AC1L7MJ9

AC1L9ZMV

AC-722

Ambotz53123-88-9

Antibiotic ay 22989

Antibiotic AY 22989

AY 22989

AY22989

AY-22989

BIDD:PXR0165

Bio1_000293

Bio1_000782

Bio1_001271

Bio2_000375

Bio2_000855

BiomolKI2_000084

C07909

C51H79NO13

CBiol_002007

CCRIS 9024

CHEBI:100923

CHEBI:9168

CHEMBL413

CID10213190

CID10795871

CID11949238

CID11959112

CID313006

CID478951

CID5040

CID5284616

CID5358081

CID5374464

CID5460439

CID5497196

CID5924240

CID6436030

CID6610270

CID6610346

CID6711160

CID6713081

CID9833581

CID9854379

CID9854380

CID9962926

CID9962928

D00753

DB00877

DE-109

DivK1c_006936

FT-0082351

heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy

HMS2089A21

HSDB 7284

KBio1_001880

KBio2_000410

KBio2_002978

KBio2_005546

KBio3_000779

KBio3_000780

KBioGR_000410

KBioSS_000410

LCP-Siro

LMPK06000003

LS-143290

MLS000028373

MolMap_000043

MolPort-003-959-433

MS-R001

NCGC00021305-05

nchembio.100-comp4

nchembio.2007.42-comp2

nchembio.79-comp1

nchembio762-comp1

nchembio883-comp3

NCI60_001851

NCIMech_000355

NSC 226080

NSC226080

Perceiva

QTL1_000069

R0395_SIAL

R0395_SIGMA

RAP

RAPA

Rapammune

Rapamune

Rapamune (TN)

rapamycin

Rapamycin

Rapamycin (TN)

Rapamycin C-7, analog 4

Rapamycin from Streptomyces hygroscopicus

Rapamycin Immunosuppressant Drug

Rapamysin

RPM

S1039_Selleck

SIIA 9268A

SILA 9268A

SILA9268A

sirolimus

Sirolimus

Sirolimús

Sirolimus (RAPAMUNE)

Sirolimus (USAN/INN)

Sirolimus [USAN:BAN:INN]

Sirolimus, Rapamune,Rapamycin

Sirolimusum

SMP1_000255

SMR000058564

SpecPlus_000840

UNII-W36ZG6FT64

UNM-0000358684

Wy 090217

WY-090217

Antibiotics, Antitubercular

Phase 2

Immunosuppressive Agents

Phase 2

Anti-Bacterial Agents

Phase 2

Immunologic Factors

Phase 2

Anti-Infective Agents

Phase 2

Antifungal Agents

Phase 2

Heparin

Approved, Investigational

9005-49-6

772 9812414

Synonyms:

101921-26-0

102785-31-9

102-94-3

104521-37-1

11078-24-3

11129-39-8

12656-11-0

37324-73-5

9041-08-1

9045-22-1

9075-96-1

913079-23-9

91449-79-5

AC1L1ROY

ALFA 87-120

ALFA 87-163

ALFA 87-198

ALFA 87-81

ALFA 88-247

Allocinnamic acid

alpha-Heparin

Alpha-Heparin

Ardeparin

Ardeparin sodium

Ariven

Arteven

Bemiparin

Bemiparin sodium

Calcilean

Calciparine

Certoparin

CID8784

cis-.beta.-Carboxystyrene

cis-Cinnamic acid

Clexane

Clivarin

Clivarine

CY 216

Cy 222

Dalteparin

Dalteparin sodium

Depo-Heparin

EINECS 232-681-7

Enoxaparin

Enoxaparin sodium

Eparina

Eparina [DCIT]

Fluxum

FR 860

Fragmin A

Fragmin B

Fragmin IV

Fraxiparin

H 2149

Hed-heparin

Hed-Heparin

Hep Flush Kit in plastic container

Hepalean

heparin

Heparin Cy 216

Heparin CY 216

Heparin Leo

Heparin Lock Flush

Heparin Lock Flush in plastic container

Heparin Lock Flush preservative free

Heparin Lock Flush preservative free in plastic container

Heparin natrium

Heparin sodium

Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container

Heparin sodium 1,000 units in dextrose 5% in plastic container

Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container

Heparin sodium 10,000 units in dextrose 5%

Heparin sodium 10,000 units in dextrose 5% in plastic container

Heparin sodium 10,000 units in sodium chloride 0.45%

Heparin sodium 10,000 units in sodium chloride 0.9%

Heparin sodium 12,500 units in dextrose 5%

Heparin sodium 12,500 units in dextrose 5% in plastic container

Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container

Heparin sodium 12,500 units in sodium chloride 0.9%

Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container

Heparin sodium 2,000 units in dextrose 5% in plastic container

Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container

Heparin sodium 20,000 units and dextrose 5% in plastic container

Heparin sodium 20,000 units in dextrose 5% in plastic container

Heparin sodium 25,000 units and dextrose 5% in plastic container

Heparin sodium 25,000 units in dextrose 5%

Heparin sodium 25,000 units in dextrose 5% in plastic container

Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container

Heparin sodium 25,000 units in sodium chloride 0.9%

Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container

Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container

Heparin sodium 5,000 units in dextrose 5% in plastic container

Heparin sodium 5,000 units in sodium chloride 0.45%

Heparin sodium 5,000 units in sodium chloride 0.9%

Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container

Heparin sodium in plastic container

Heparin sodium preservative Free

Heparin sodium salt

Heparin sulfate

Heparin sulphate

Heparin, sodium salt

Heparina

Heparina [INN-Spanish]

Heparinate

Heparine

Heparine [INN-French]

Heparinic acid

Heparinsodiumsalt

Heparinum

Heparinum [INN-Latin]

Heparinum natricum

Hepathrom

Hepflush-10

Hep-Lock

Hep-Lock U/P

HSDB 3094

Innohep

Inno-Hep

Isocinnamic acid

Kabi 2165

KB 101

Leparan

LHN 1

Lioton 1000

Lipo-hepin

Lipo-Hepin

Liquaemin

Liquaemin Lock Flush

Liquaemin Sodium

Liquaemin sodium preservative free

Liquemin

Logiparin

Low molecular weight heparin sodium

Minolteparin sodium

MolPort-003-760-257

Multiparin

Nadroparin

Nadroparine

Novoheparin

NSC174025

Octaparin

OP 386

OP 622

Pabyrin

Panheprin

Parnaparin

Parnaparin sodium

Parvoparin

Pularin

Reviparin

Reviparin sodium

Ro 11

Sandoparin

Sodium acid heparin

Sodium heparin

Sodium heparinate

Subeparin

Sublingula

Thromboliquine

Tinzaparin

Tinzaparin sodium

Triofiban

Unfractionated heparin

UNII-12M44VTJ7B

UNII-3S182ET3UA

UNII-E47C0NF7LV

UNII-T2410KM04A

UNII-ZZ45AB24CA

Vetren

Vitrum AB

WY 90493RD

Nadroparin

Approved, Investigational

Lidocaine

Approved, Vet_approved

137-58-6

3676

Synonyms:

.alpha.-(Diethylamino)-2,6-acetoxylidide

.alpha.-Diethylamino-2,6-dimethylacetanilide

.alpha.-Diethylaminoaceto-2,6-xylidide

.omega.-Diethylamino-2,6-dimethylacetanilide

137-58-6

2-(Diethylamino)-2',6'-acetoxylidide

2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide

2-2ETN-2MePhAcN

2-Diethylamino-N-(2,6-dimethylphenyl)acetamide

2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide

4-12-00-02538 (Beilstein Handbook Reference)

6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))

6108-05-0 (mono-hydrochloride, mono-hydrate)

73-78-9 (mono-hydrochloride)

AB00053581

AC-10282

AC1L1GGQ

AC1Q2Z7J

a-Diethylamino-2,6-dimethylacetanilide

After Burn Double Strength Gel

After Burn Double Strength Spray

After Burn Gel

After Burn Spray

AKOS001026768

alfa-Dietilamino-2,6-dimetilacetanilide

alfa-Dietilamino-2,6-dimetilacetanilide [Italian]

Alphacaine

alpha-diethylamino-2,6-dimethylacetanilide

alpha-Diethylamino-2,6-dimethylacetanilide

Anestacon

Anestacon Jelly

ARONIS23855

Astrazeneca brand OF lidocaine

BIDD:GT0342

Bio-0767

Bio1_000379

Bio1_000868

Bio1_001357

Bio2_000079

Bio2_000559

BPBio1_000197

BRD-K52662033-001-02-6

BRD-K52662033-003-05-5

BRN 2215784

BSPBio_000179

BSPBio_001359

BSPBio_003004

C07073

C14H22N2O

Cappicaine

CAS-73-78-9

CDS1_000283

CHEBI:6456

CHEMBL79

CID3676

Cito optadren

CPD000058189

Cuivasil

D00358

Dalcaine

DB00281

Dentipatch

Dentipatch (TN)

DermaFlex

Diethylaminoaceto-2,6-xylidide

Dilocaine

DivK1c_000174

DivK1c_001323

Duncaine

EINECS 205-302-8

ELA-Max

EMBOLEX

Emla Cream

Esracaine

FT-0082378

Gravocain

HMS1791D21

HMS1989D21

HMS2051C21

HMS2089E15

HMS548M19

HSDB 3350

I01-2704

IDI1_000174

IDI1_033829

Isicaina

Isicaine

Jenapharm brand OF lidocanine hydrochloride

Jetocaine

KBio1_000174

KBio2_000079

KBio2_001598

KBio2_002647

KBio2_004166

KBio2_005215

KBio2_006734

KBio3_000157

KBio3_000158

KBio3_002224

KBioGR_000079

KBioGR_000599

KBioSS_000079

KBioSS_001598

L0156

L1026_SIGMA

L7757_SIGMA

Lanabiotic

L-Caine

Leostesin

Lida-Mantle

Lidocaina

Lidocaína

Lidocaina [INN-Spanish]

lidocaine

Lidocaine

LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)

Lidocaine (JP15/USP/INN)

Lidocaine (VAN)

Lidocaine [USAN:INN:JAN]

Lidocaine carbonate

Lidocaine Carbonate

Lidocaine carbonate (2:1)

Lidocaine hydrocarbonate

Lidocaine Hydrocarbonate

Lidocaine hydrochloride

Lidocaine monoacetate

Lidocaine monohydrochloride

Lidocaine Monohydrochloride

Lidocaine monohydrochloride, monohydrate

Lidocaine sulfate (1:1)

Lidocainum

Lidocainum [INN-Latin]

Lidocaton

Lidoderm

Lidoject-1

Lidoject-2

LIDOPEN

Lignocaine

Lignocainum

Lingocaine

Lopac0_000669

Lopac-L-5647

LQZ

LS-805

Maricaine

Maybridge1_002571

MLS000069724

MLS000758263

MLS001074177

MolPort-001-783-478

N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide

N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide

NCGC00015611-01

NCGC00015611-02

NCGC00015611-03

NCGC00015611-04

NCGC00015611-14

NCGC00022176-05

NCGC00022176-06

NCGC00022176-07

NCGC00022176-08

NCGC00022176-09

nchembio.65-comp16

NINDS_000174

Norwood Sunburn Spray

Novocol brand OF lidocaine hydrochloride

NSC 40030

NSC40030

Octocaine

Octocaine-100

Octocaine-50

Prestwick0_000050

Prestwick1_000050

Prestwick2_000050

Prestwick3_000050

Remicaine

Rocephin Kit

Rucaina

S1357_Selleck

SAM001247018

SMR000058189

Solarcaine aloe extra burn relief cream

Solcain

SPBio_001525

SPBio_002100

Spectrum_001118

Spectrum2_001343

Spectrum3_001392

Spectrum4_000070

Spectrum5_001549

STK552033

Strathmann brand OF lidocaine hydrochloride

UNII-98PI200987

WLN: 2N2 & 1VMR B1 F1

Xilina

Xilocaina

Xilocaina [Italian]

Xllina

Xycaine

Xylestesin

Xylesthesin

Xylocain

Xylocaine

Xylocaine (TN)

Xylocaine 5% Spinal

Xylocaine CO2

Xylocaine Dental Ointment

Xylocaine Endotracheal

Xylocaine Test Dose

Xylocaine Viscous

Xylocaine-Mpf

Xylocaine-Mpf with Glucose

Xylocard

Xylocitin

Xyloneural

Xyloneural (free base)

Xylotox

Zilactin-L

Zingo

α-diethylamino-2,6-dimethylacetanilide

Α-diethylamino-2,6-dimethylacetanilide

insulin

Hormones

Insulin, Globin Zinc

calcium heparin

Anti-Arrhythmia Agents

Anesthetics

Sodium Channel Blockers

Anesthetics, Local

Diuretics, Potassium Sparing

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy : A Prospective, Randomized, Controlled Study	Unknown status	NCT02097446	Phase 3
2	A Prospective Randomised Phase III Trial to Evaluate Optimal Treatment Duration of First-line Bevacizumab in Combination With Carboplatin and Paclitaxel in Patients With Primary Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer	Active, not recruiting	NCT01462890	Phase 3	Paclitaxel;Carboplatin
3	Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma	Completed	NCT01460979	Phase 2	Temsirolimus
4	Effect of Metabolic Variations Upon the Activity of the Neuroendocrine Reproductive Axis in Normal Female Volunteers	Completed	NCT02233283
5	Effect of Total Salpingectomy During Conservative Hysterectomy for Benign Disease on Ovarian Function: Non Inferiority Randomized Controlled Trial	Completed	NCT01628432
6	Studio Pilota Farmacocinetico-clinico Sulla Somministrazione di Eparina a Basso Peso Molecolare e Dosaggio Sierico di HGF Nelle Pazienti Operate Affette da Patologie Ginecologiche	Completed	NCT01523652
7	The Effect of Buffered Lidocaine Versus Nonbuffered Lidocaine on Pain Scores During Infiltration for Vulvar Biopsies	Completed	NCT02698527		Non-Buffered Lidocaine;Buffered Lidocaine
8	A Long Term Follow up of Perigee Anterior Meshes Performed for Recurrent Prolapse	Completed	NCT02642835
9	Study of Ovarian Function and Gynecological Profile of Patients Carrying a Pathogenic Variant of the HNF1B Gene (GYN-HNF1)	Not yet recruiting	NCT04746053

Search NIH Clinical Center for Female Reproductive System Disease

Cochrane evidence based reviews: genital diseases, female

Sources

Genetic Tests for Female Reproductive System Disease

Sources

Anatomical Context for Female Reproductive System Disease

MalaCards organs/tissues related to Female Reproductive System Disease:

⁴⁰

Uterus, Cervix, Breast

Sources

Publications for Female Reproductive System Disease

Articles related to Female Reproductive System Disease:

#	Title	Authors	PMID	Year
1	[Analysis on reproductive health status and influencing factors of female workers of pharmaceutical industry in Gansu province]. ⁶¹	Kou ZX...Zhou AS	22356709	2011

Sources

Genes for Female Reproductive System Disease

Genes related to Female Reproductive System Disease (0 elite genes):

(show top 50) (show all 107)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	MIR199A1	MicroRNA 199a-1	RNA Gene	17.15	DISEASES inferred ¹⁵ ¹⁵ ¹⁵
2	MIR21	MicroRNA 21	RNA Gene	12.99	DISEASES inferred ¹⁵ ¹⁵
3	H2AC18	H2A Clustered Histone 18	Protein Coding	12.63	DISEASES inferred ¹⁵ ¹⁵
4	MIR141	MicroRNA 141	RNA Gene	12.34	DISEASES inferred ¹⁵ ¹⁵
5	MIR145	MicroRNA 145	RNA Gene	12.23	DISEASES inferred ¹⁵ ¹⁵
6	MIR17	MicroRNA 17	RNA Gene	12.18	DISEASES inferred ¹⁵ ¹⁵
7	MIR200A	MicroRNA 200a	RNA Gene	12.14	DISEASES inferred ¹⁵ ¹⁵
8	MIR518D	MicroRNA 518d	RNA Gene	12.13	DISEASES inferred ¹⁵ ¹⁵ ¹⁵
9	MIR214	MicroRNA 214	RNA Gene	11.87	DISEASES inferred ¹⁵ ¹⁵
10	MIR9-1	MicroRNA 9-1	RNA Gene	11.85	DISEASES inferred ¹⁵ ¹⁵
11	MIR196A1	MicroRNA 196a-1	RNA Gene	11.78	DISEASES inferred ¹⁵ ¹⁵
12	CCR6	C-C Motif Chemokine Receptor 6	Protein Coding	11.65	DISEASES inferred ¹⁵ ¹⁵
13	MIR30A	MicroRNA 30a	RNA Gene	11.62	DISEASES inferred ¹⁵ ¹⁵
14	MIR143	MicroRNA 143	RNA Gene	11.6	DISEASES inferred ¹⁵ ¹⁵
15	MIR34A	MicroRNA 34a	RNA Gene	11.56	DISEASES inferred ¹⁵ ¹⁵
16	MIR200B	MicroRNA 200b	RNA Gene	11.48	DISEASES inferred ¹⁵ ¹⁵
17	MIR518A1	MicroRNA 518a-1	RNA Gene	11.48	DISEASES inferred ¹⁵ ¹⁵ ¹⁵
18	MIR193A	MicroRNA 193a	RNA Gene	11.37	DISEASES inferred ¹⁵ ¹⁵
19	MIR27A	MicroRNA 27a	RNA Gene	11.3	DISEASES inferred ¹⁵ ¹⁵
20	MIR205	MicroRNA 205	RNA Gene	11.28	DISEASES inferred ¹⁵ ¹⁵
21	MIR142	MicroRNA 142	RNA Gene	11.25	DISEASES inferred ¹⁵ ¹⁵
22	MIR139	MicroRNA 139	RNA Gene	11.24	DISEASES inferred ¹⁵ ¹⁵
23	MIR126	MicroRNA 126	RNA Gene	11.22	DISEASES inferred ¹⁵ ¹⁵
24	MIR146A	MicroRNA 146a	RNA Gene	11.18	DISEASES inferred ¹⁵ ¹⁵
25	MIR125A	MicroRNA 125a	RNA Gene	11.16	DISEASES inferred ¹⁵ ¹⁵
26	MIR182	MicroRNA 182	RNA Gene	11.16	DISEASES inferred ¹⁵ ¹⁵
27	MIR31	MicroRNA 31	RNA Gene	11.15	DISEASES inferred ¹⁵ ¹⁵
28	SERPINA3	Serpin Family A Member 3	Protein Coding	11.04	DISEASES inferred ¹⁵ ¹⁵
29	ICOSLG	Inducible T Cell Costimulator Ligand	Protein Coding	11	DISEASES inferred ¹⁵ ¹⁵
30	MIRLET7A1	MicroRNA Let-7a-1	RNA Gene	10.98	DISEASES inferred ¹⁵ ¹⁵
31	MIR15A	MicroRNA 15a	RNA Gene	10.97	DISEASES inferred ¹⁵ ¹⁵
32	MIR221	MicroRNA 221	RNA Gene	10.96	DISEASES inferred ¹⁵ ¹⁵
33	MIR140	MicroRNA 140	RNA Gene	10.94	DISEASES inferred ¹⁵ ¹⁵
34	MIR106B	MicroRNA 106b	RNA Gene	10.92	DISEASES inferred ¹⁵ ¹⁵
35	MIR10B	MicroRNA 10b	RNA Gene	10.83	DISEASES inferred ¹⁵ ¹⁵
36	MIR181A1	MicroRNA 181a-1	RNA Gene	10.76	DISEASES inferred ¹⁵ ¹⁵
37	MIR518E	MicroRNA 518e	RNA Gene	10.75	DISEASES inferred ¹⁵ ¹⁵ ¹⁵
38	MIR34C	MicroRNA 34c	RNA Gene	10.74	DISEASES inferred ¹⁵ ¹⁵
39	MIR22	MicroRNA 22	RNA Gene	10.72	DISEASES inferred ¹⁵ ¹⁵
40	MIR483	MicroRNA 483	RNA Gene	10.71	DISEASES inferred ¹⁵ ¹⁵
41	MIR93	MicroRNA 93	RNA Gene	10.67	DISEASES inferred ¹⁵ ¹⁵
42	MIR486-1	MicroRNA 486-1	RNA Gene	10.63	DISEASES inferred ¹⁵ ¹⁵
43	MIR183	MicroRNA 183	RNA Gene	10.63	DISEASES inferred ¹⁵ ¹⁵
44	MIR223	MicroRNA 223	RNA Gene	10.62	DISEASES inferred ¹⁵ ¹⁵
45	MIR29A	MicroRNA 29a	RNA Gene	10.61	DISEASES inferred ¹⁵ ¹⁵
46	U2AF1	U2 Small Nuclear RNA Auxiliary Factor 1	Protein Coding	10.59	DISEASES inferred ¹⁵ ¹⁵
47	MIR125B1	MicroRNA 125b-1	RNA Gene	10.54	DISEASES inferred ¹⁵ ¹⁵
48	MIR15B	MicroRNA 15b	RNA Gene	10.52	DISEASES inferred ¹⁵ ¹⁵
49	MIR130B	MicroRNA 130b	RNA Gene	10.51	DISEASES inferred ¹⁵ ¹⁵
50	MIR424	MicroRNA 424	RNA Gene	10.5	DISEASES inferred ¹⁵ ¹⁵

Sources

Variations for Female Reproductive System Disease

Sources

Expression for Female Reproductive System Disease

Search GEO for disease gene expression data for Female Reproductive System Disease.

Sources

Pathways for Female Reproductive System Disease

Pathways related to Female Reproductive System Disease according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	MicroRNAs in cancer ³⁶	11.96	MIR9-1 MIR34A MIR30A MIR27A MIR214 MIR21
2	miRNA targets in ECM and membrane receptors ¹	10.77	MIR200B MIR200A MIR141
3	SRF and miRs in Smooth Muscle Differentiation and Proliferation ¹	10.27	MIR199A1 MIR145

Sources

GO Terms for Female Reproductive System Disease

Cellular components related to Female Reproductive System Disease according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	extracellular space	GO:0005615	9.56	MIR30A MIR27A MIR21 MIR205 MIR199A1 MIR17
2	extracellular vesicle	GO:1903561	9.17	MIR34A MIR30A MIR27A MIR214 MIR21 MIR193A

Biological processes related to Female Reproductive System Disease according to GeneCards Suite gene sharing:

(show all 28)

#	Name	GO ID	Score	Top Affiliating Genes
1	negative regulation of gene expression	GO:0010629	9.93	MIR34A MIR27A MIR214 MIR21 MIR200B MIR17
2	positive regulation of angiogenesis	GO:0045766	9.87	MIR30A MIR21 MIR199A1 MIR143
3	negative regulation of cell migration	GO:0030336	9.83	MIR9-1 MIR34A MIR214 MIR21 MIR145
4	negative regulation of cell migration involved in sprouting angiogenesis	GO:0090051	9.77	MIR199A1 MIR196A1 MIR193A
5	positive regulation of blood vessel endothelial cell migration	GO:0043536	9.76	MIR30A MIR200A MIR143
6	negative regulation of cardiac muscle cell apoptotic process	GO:0010667	9.71	MIR21 MIR199A1 MIR145
7	negative regulation of angiogenesis	GO:0016525	9.7	MIR34A MIR214 MIR21 MIR200B MIR193A MIR145
8	negative regulation of vascular associated smooth muscle cell migration	GO:1904753	9.69	MIR34A MIR214 MIR21
9	negative regulation of low-density lipoprotein particle clearance	GO:0010989	9.67	MIR27A MIR199A1 MIR17
10	positive regulation of vascular smooth muscle cell proliferation	GO:1904707	9.67	MIR27A MIR214 MIR21 MIR17
11	positive regulation of connective tissue replacement	GO:1905205	9.65	MIR34A MIR214 MIR199A1
12	negative regulation of cardiac muscle hypertrophy	GO:0010614	9.64	MIR21 MIR145
13	regulation of smooth muscle contraction	GO:0006940	9.63	MIR145 MIR143
14	positive regulation of cardiac muscle cell apoptotic process	GO:0010666	9.63	MIR34A MIR17
15	negative regulation of vascular wound healing	GO:0061044	9.62	MIR34A MIR200B
16	angiotensin-activated signaling pathway	GO:0038166	9.62	MIR145 MIR143
17	negative regulation of interleukin-1-mediated signaling pathway	GO:2000660	9.61	MIR27A MIR21
18	negative regulation of vascular associated smooth muscle cell apoptotic process	GO:1905460	9.61	MIR21 MIR17
19	negative regulation of lamellipodium assembly	GO:0010593	9.6	MIR214 MIR196A1
20	aorta smooth muscle tissue morphogenesis	GO:0060414	9.58	MIR145 MIR143
21	positive regulation of cardiac muscle hypertrophy in response to stress	GO:1903244	9.58	MIR214 MIR199A1 MIR17
22	gene silencing by miRNA	GO:0035195	9.58	MIR9-1 MIR518D MIR518A1 MIR34A MIR30A MIR27A
23	positive regulation of pulmonary blood vessel remodeling	GO:1905111	9.56	MIR17 MIR143
24	negative regulation of vascular endothelial growth factor production	GO:1904046	9.56	MIR34A MIR205 MIR199A1 MIR17
25	regulation of phenotypic switching	GO:1900239	9.55	MIR145 MIR143
26	establishment or maintenance of cell type involved in phenotypic switching	GO:0044663	9.52	MIR145 MIR143
27	positive regulation of metalloendopeptidase activity	GO:1904685	9.5	MIR21 MIR205 MIR17
28	miRNA mediated inhibition of translation	GO:0035278	9.5	MIR9-1 MIR27A MIR21 MIR205 MIR200B MIR17

Molecular functions related to Female Reproductive System Disease according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	mRNA 3'-UTR binding	GO:0003730	9.73	MIR9-1 MIR34A MIR30A MIR27A MIR21 MIR205
2	mRNA binding involved in posttranscriptional gene silencing	GO:1903231	9.55	MIR9-1 MIR518A1 MIR34A MIR30A MIR27A MIR214

Sources

Sources for Female Reproductive System Disease

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GARD

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MedlinePlus Genetics

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 05-Apr-2021)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ Tocris

⁷⁰ UMLS

⁷¹ UMLS via Orphanet

⁷² UniProtKB/Swiss-Prot

⁷³ Wikipedia